wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38855121-5888A770-FF26-4922-8DED-F236CA674D6B
Q38855121-5888A770-FF26-4922-8DED-F236CA674D6B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38855121-5888A770-FF26-4922-8DED-F236CA674D6B
CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population.
P2860
Q38855121-5888A770-FF26-4922-8DED-F236CA674D6B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38855121-5888A770-FF26-4922-8DED-F236CA674D6B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0633bc616c47797b03c55857fb4ff6259cdb3571
P2860
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.